Development of antidiabetic nanomedicine from stevioside

Stevioside, a non-caloric sweetener has huge therapeutic potential as an antidiabetic biomolecule. Stevioside nano-bioconjugated on PEG-PLA nanoparticles of size 150-170 nm showed the initial burst phase followed by the slow controlled release of 2 h and 21 days respectively.